Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. How COVID-19 has affected emergent visits to a Latin-American trauma department: Experience at a Peruvian national trauma referral center.Injury · 2020
   Observational
2. Infections and diabetes: Risks and mitigation with reference to India.Diabetes & metabolic syndrome
   Review
3. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India.Diabetes & metabolic syndrome
   Review
4. Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India.Diabetes & metabolic syndrome
   Article
5. Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India.Diabetes & metabolic syndrome
   Observational
6. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.Diabetes & metabolic syndrome
   Review
7. At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19.Diabetes & metabolic syndrome
   Review
8. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification.Diabetes & metabolic syndrome
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as